AAB
ABBV icon

ABN AMRO Bank’s AbbVie ABBV Stock Holding History

ABN AMRO Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.2M Sell
394,664
-469,725
-54% -$101M 1.28% 24
2026
Q1 		$190M Sell
864,389
-49,474
-5% -$11M 2.05% 17
2025
Q4 		$208M Sell
913,863
-19,212
-2% -$4.38M 1.96% 19
2025
Q3 		$215M Buy
933,075
+9,087
+1% +$1.85M 2.12% 17
2025
Q2 		$173M Buy
923,988
+6,711
+0.7% +$1.25M 2.25% 18
2025
Q1 		$192M Sell
917,277
-93,175
-9% -$18.1M 2.65% 13
2024
Q4 		$178M Sell
1,010,452
-154,191
-13% -$28.3M 2.4% 18
2024
Q3 		$228M Buy
1,164,643
+16,036
+1% +$2.99M 3.13% 12
2024
Q2 		$199M Buy
1,148,607
+4,449
+0.4% +$737K 3.01% 13
2024
Q1 		$209M Buy
1,144,158
+1,136,730
+15,303% +$196M 3.12% 11
2023
Q4 		$1.16M Sell
7,428
-2,742
-27% -$400K 0.02% 106
2023
Q3 		$1.52M Sell
10,170
-4,310
-30% -$633K 0.03% 94
2023
Q2 		$1.95M Sell
14,480
-3,771
-21% -$553K 0.04% 88
2023
Q1 		$2.92M Buy
+18,251
New +$2.79M 0.07% 76

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ABN AMRO Bank's ABBV Position: Q2 2026 in Review

ABN AMRO Bank reduced its AbbVie (ABBV) stake by 54% in Q2 2026, selling an estimated $101M and leaving 394,664 shares worth $99.2M. The position accounts for 1.28% of the portfolio, ranked #24.

ABN AMRO Bank first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. The position peaked at $228M in Q3 2024. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ABN AMRO Bank held 394,664 shares of AbbVie worth $99.2M as of Q2 2026.
  • ABN AMRO Bank sold 469,725 AbbVie shares in Q2 2026, an estimated $101M.
  • AbbVie made up 1.28% of ABN AMRO Bank's portfolio in Q2 2026, its #24 holding.
  • ABN AMRO Bank first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Bank's AbbVie position peaked at $228M in Q3 2024.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.